8.52122

Fmoc-Asp(OAll)-OH

≥98.0% (acidimetric), for peptide synthesis, Novabiochem^®

• Synonym(e): Fmoc-Asp(OAll)-OH
• Empirische Formel (Hill-System): C₂₂H₂₁NO₆
• CAS-Nummer: 146982-24-3
• Molekulargewicht: 395.41
• UNSPSC Code: 12352209
• NACRES: NA.22
• MDL number: MFCD00190874

Eigenschaften

• Produktname: Fmoc-Asp(OAll)-OH, Novabiochem^®
• Quality Segment: 200
• product line: Novabiochem^®
• assay: ≥98% (TLC), ≥98.0% (HPLC), ≥98.0% (acidimetric)
• form: powder
• reaction suitability: reaction type: Fmoc solid-phase peptide synthesis
• manufacturer/tradename: Novabiochem^®
• mp: 111-114 °C
• application(s): peptide synthesis
• functional group: carboxylic acid
• storage temp.: 2-30°C
• SMILES string: N([C@@H](CC(=O)OCC=C)C(=O)O)C(=O)OCC1c2c(cccc2)c3c1cccc3
• InChI: 1S/C22H21NO6/c1-2-11-28-20(24)12-19(21(25)26)23-22(27)29-13-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h2-10,18-19H,1,11-13H2,(H,23,27)(H,25,26)/t19-/m0/s1
• InChI key: FBNFRRNBFASDKS-IBGZPJMESA-N

Beschreibung

General description

Orthogonally-protected building block for the synthesis of peptides modified at the Asp side chain by Fmoc SPPS. See entry for 852072 for more details.04-12-1303

Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS
Guide to Selection of Orthogonally -Protected Building Blocks for Fmoc SPPS

Analysis Note

Color (visual): white to slight yellow to beige
Appearance of substance (visual): powder
Identity (IR): passes test
Optical rotation α 25/D (c=1 in DMF): -30.0 - -25.0 °
Purity (TLC(157A)): ≥ 98 %
Assay (HPLC, area%): ≥ 98.0 % (a/a)
Solubility (1 mmole in 2 ml DMF): clearly soluble
Assay (acidimetric): ≥ 98.0 %
Water (K. F.): ≤ 1.0 %

To see the solvent systems used for TLC of Novabiochem^® products please click here.

Other Notes

Replaces: 04-12-1303

Legal Information

Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable